Evidence map›Paper›PMID 39372693›Full record

ArticleThe Pan African medical journal2024

Rubella seroprevalence among unvaccinated school-aged children in Jos, North Central, Nigeria.

Hyelshilni Samuel Waziri, Fatima Giwa, Adebola Tolulope Olayinka, Ndadilnasiya Endie Waziri, Clement Koeloengan Da'am, Yahaya Mohammed, Patrick Nguku, Samuel Abednego Dahal, Ugochukwu Nwokoro, Joseph Nakah and 2 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hyelshilni Samuel WaziriAfrican Field Epidemiology Network, Abuja, Nigeria.
Fatima GiwaAhmadu Bello University Zaria, Kaduna State, Nigeria.
Adebola Tolulope OlayinkaAhmadu Bello University Zaria, Kaduna State, Nigeria.
Ndadilnasiya Endie WaziriAfrican Field Epidemiology Network, Abuja, Nigeria.
Clement Koeloengan Da'amAfrica Centres for Disease Control and Prevention, Jabi, Abuja, Nigeria.
Yahaya MohammedAfrican Field Epidemiology Network, Abuja, Nigeria.
Patrick NgukuAfrican Field Epidemiology Network, Abuja, Nigeria.
Samuel Abednego DahalDepartment of Medical Microbiology, Jos University Teaching Hospital, Plateau State, Nigeria.
Ugochukwu NwokoroDepartment of Community Medicine, University of Nigeria Teaching Hospital, Enugu State, Nigeria.
Joseph NakahDepartment of Medical Microbiology, Jos University Teaching Hospital, Plateau State, Nigeria.
Yadang Dasohot MaktepDepartment of Medical Microbiology, Jos University Teaching Hospital, Plateau State, Nigeria.
Ahmed Olowo-OkereDepartment of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Abuja, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: rubella poses a significant public health threat, particularly in developing countries, where congenital rubella remains a preventable concern. This cross-sectional study examined rubella seroprevalence among children aged 10 and under from May to September 2016 in Jos, Nigeria. Methods: using a multistage sampling method, eligible participants who had not been vaccinated against the rubella virus and consented to participate in the study were recruited across schools in the city. Rubella-specific IgG and IgM antibodies were detected from eluted serum collected from the participants using the enzyme-linked immunosorbent assay (ELISA). Data analysis and visualization was done using the R software version 4.3.1. Results: of the 405 participants investigated in this study, 336 (82.96%) tested positive for rubella IgG, while 9 (2.22%) tested positive for rubella IgM. Factors such as age ≥ 5 years and lack of Western education showed significant associations with rubella seropositivity. Conclusion: this study highlights the seroprevalence of rubella IgG and IgM antibodies among children aged 10 and under in Jos, Nigeria. The significant associations between rubella seropositivity and factors such as age ≥ 5 years and lack of Western education underscore the necessity for an effective rubella vaccination program to prevent congenital rubella syndrome (CRS).

Indexed as

Antibodies, ViralEnzyme-Linked Immunosorbent AssayImmunoglobulin GImmunoglobulin MRubellaAge FactorsChildChild, PreschoolCross-Sectional StudiesFemaleHumansMaleNigeriaRubella Syndrome, CongenitalRubella VaccineRubella virusAntibodies, ViralImmunoglobulin GImmunoglobulin Mrubella antibodiesRubella VaccineimmunizationNigeriaRubella virusseroprevalence

Identifiers

PMID39372693
PMCPMC11453113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.